Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
PPP1R8, through alternative splicing, encodes three different isoforms. Additionally we are shipping Protein Phosphatase 1, Regulatory Subunit 8 Proteins (9) and Protein Phosphatase 1, Regulatory Subunit 8 Kits (1) and many more products for this protein.
Showing 10 out of 96 products:
Human Monoclonal PPP1R8 Primary Antibody for IF, WB - ABIN393761
Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. in Diabetes Care 2010
Show all 5 references for ABIN393761
Cow (Bovine) Polyclonal PPP1R8 Primary Antibody for WB - ABIN2778805
Kumeta, Ogura, Adachi, Fujioka, Tanuma, Tanuma, Kikuchi, Inagaki: The NMR structure of the NIPP1 FHA domain. in Journal of biomolecular NMR 2008
Cow (Bovine) Polyclonal PPP1R8 Primary Antibody for EIA, IHC (p) - ABIN374344
Nuytten, Beke, Van Eynde, Ceulemans, Beullens, Van Hummelen, Fuks, Bollen: The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing. in Oncogene 2008
Chicken Polyclonal PPP1R8 Primary Antibody for WB - ABIN2779048
Lesage, Beullens, Nuytten, Van Eynde, Keppens, Himpens, Bollen: Interactor-mediated nuclear translocation and retention of protein phosphatase-1. in The Journal of biological chemistry 2004
Human Polyclonal PPP1R8 Primary Antibody for IHC, ELISA - ABIN185050
Beullens, Bollen: The protein phosphatase-1 regulator NIPP1 is also a splicing factor involved in a late step of spliceosome assembly. in The Journal of biological chemistry 2002
Human Naa15 (NATH (show NAA15 Antibodies)) and Naa10 (ARD1 (show ARD1A Antibodies)) form a stable NatA complex which associates with ribosomes and performs co-translational N-terminal acetylation; Naa15 (NATH (show NAA15 Antibodies)) and Naa10 (ARD1 (show ARD1A Antibodies)) are cleaved during apoptosis resulting in decreased acetyltransferase activity
The clinical spectrum of NAA10 (show ARD1A Antibodies).
there is no difference in lysine acetylation of substrate proteins with or without Naa10 (show ARD1A Antibodies), suggesting that the substrates may be acetylated chemically rather than enzymatically.
Combined high expression of Naa10p, SNCG (show SNCG Antibodies) and PRL-3 are associated with lymph node metastasis in breast cancer.
De novo missense mutations in the NAA10 (show ARD1A Antibodies) gene cause severe non-syndromic developmental delay in males and females
human ARD1 (show TRIM23 Antibodies) variants have different effects on cell proliferation, which may result from distinct subcellular localizations and autoacetylation activities.
Naa10 (show ARD1A Antibodies) structure and function. [Review]
Autoacetylation of ARD1 (show TRIM23 Antibodies) variants differentially regulates angiogenesis and cell proliferation in an isoform-specific manner.
Data suggest overexpression of NIPP1 in HeLa cells causes induction of genes of mesenchymal lineage with reduction in cell proliferation; thus, key dephosphorylation events may be involved in epithelial-mesenchymal transition or transdifferentiation.
ARD1 (show TRIM23 Antibodies) has a crucial role in the cellular response to oxidative stress as a bona fide regulator of MSRA (show MSRA Antibodies).
activation of the RAGE (show AGER Antibodies) by advanced glycation end products or other ligands suppresses NIPP1 expression in diabetic nephropathy, contributes to podocyte hypertrophy, and glomerular inflammation
NIPP1(-/-) embryos showed severely retarded growth at embryonic day 6.5 (E6.5) and were resorbed by E8.5. This early embryonic lethality was not associated with increased apoptosis but correlated with impaired cell proliferation.
NIPP1 has a role in the nuclear targeting and/or retention of PP1 (show PPP1CC Antibodies)
Required for the global trimethylation of Histone 3 at Lysine 27 and is implicated in gene silencing by enhancer of zeste homolog (EZH)2 (show EZH2 Antibodies).
This gene, through alternative splicing, encodes three different isoforms. Two of the protein isoforms encoded by this gene are specific inhibitors of type 1 serine/threonine protein phosphatases and can bind but not cleave RNA. The third protein isoform lacks the phosphatase inhibitory function but is a single-strand endoribonuclease comparable to RNase E of E. coli. This isoform requires magnesium for its function and cleaves specific sites in A+U-rich regions of RNA.
ARD1 homolog A, N-acetyltransferase
, N-acetyltransferase ARD1, human homolog of
, N-alpha-acetyltransferase 10
, N-alpha-acetyltransferase 10, NatA catalytic subunit
, N-terminal acetyltransferase complex ARD1 subunit homolog A
, nuclear inhibitor of protein phosphatase 1
, protein phosphatase 1 regulatory inhibitor subunit 8
, protein phosphatase 1, regulatory (inhibitor) subunit 8
, protein phosphatase 1, regulatory inhibitor subunit 8
, RNase E
, activator of RNA decay
, nuclear inhibitor of protein phosphatase-1 alpha
, nuclear subunit of PP-1
, protein phosphatase 1 regulatory subunit 8
, uncharacterized protein LOC799896